Form 4: VolitionRx CEO Cameron John Reynolds Receives Stock Award in Lieu of Cash Compensation

Cameron John Reynolds, CEO of VolitionRx Ltd, received 90,182 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• Cameron John Reynolds, the President and CEO of VolitionRx Ltd, filed a Form 4 on June 4, 2024, reporting changes in beneficial ownership.
• On June 1, 2024, Reynolds was awarded 90,182 restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
• These RSUs were granted in lieu of cash compensation.
• The RSUs vest in three installments: 30,061 units on June 1, 2024, 30,061 units on July 1, 2024, and 30,060 units on August 1, 2024.
• The RSUs are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date.
• Upon vesting and settlement, Reynolds will receive common stock equal to the number of RSUs that have vested.
• Reynolds directly owns 1,844,850 shares of VolitionRx common stock.
• He also indirectly owns 1,007,718 shares through Concord International, Inc., where he is the majority shareholder and shares voting and dispositive control.
• Additionally, he indirectly owns 34,076 shares through his spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock awards, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acceptance of RSUs in lieu of cash compensation may indicate a belief in the company's future prospects by the CEO.

Future Outlook

The vesting schedule of the RSUs extends to May 1, 2025, suggesting a continued commitment from the CEO to the company's long-term performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies and their insiders, providing transparency into the ownership positions and transactions of key individuals.

Stakeholder Impact

• The stock award to the CEO aligns his interests with those of shareholders, potentially incentivizing him to drive long-term value creation.

Key Dates